Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer

Experimental and Therapeutic Medicine

Volumn 1, Issue 3, 2010, Pages 457-462

  Jensen, Kirk ^a   Patel, Aneeta ^a   Hoperia, Victoria ^b   Larin, Alexander ^b   Bauer, Andrew ^a   Vasko, Vasyl ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Transplantation of Endocrine Organs and Tissues   (Ukraine)

Author keywords

Cancer; E cadherin; Epigenetic; Metastasis; Methylation; Thyroid

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; EPIGENETICS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYME CELL; METHYLATION; PAPILLARY CARCINOMA; PHENOTYPE; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA;

EID: 77956210500     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000071     Document Type: Article

References (26)

1. Puxeddu E and Filetti S: The 2009 American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer: progress on the road from consensus- to evidence-based practice. Thyroid 19: 1145-1147, 2009.
2. Shook D and Keller R: Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 120: 1351-1383, 2003.
3. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
4. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991.
5. Matteucci E, Ridolfi E and Desiderio MA: Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells. Cell Mol Life Sci 63: 2016-2026, 2006.
6. Wang H, Radjendirane V, Wary KK and Chakrabarty S: Transforming growth factor beta regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23: 5558-5561, 2004.
7. Honma N, Genda T, Matsuda Y, Yamagiwa S, Takamura M, Ichida T and Aoyagi Y: MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells. Lab Invest 86: 687-696, 2006.
8. Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB and Herman JG: E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin Cancer Res 6: 4243-4248, 2000.
9. Gagnon J, Shaker S, Primeau M, Hurtubise A and Momparler RL: Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anticancer Drugs 14: 193-202, 2003.
10. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, Rognum TOTO, Esteller M and Lothe RA: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer 3: 28, 2004.
11. Jaggi M, Rao PS, Smith DJ, Wheelock MJ, Johnson KR, Hemstreet GP and Balaji KC: E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res 65: 483-492, 2005.
12. Le TL, Joseph SR, Yap AS and Stow JL: Protein kinase C regulates endocytosis and recycling of E-cadherin. Am J Physiol Cell Physiol 283: C489-C499, 2002.
13. Takahashi E, Nagano O, Ishimoto T, Yae T, Suzuki Y, Shinoda T T, Nakamura S, Niwa S, Ikeda S, Koga H, Tanihara H and Saya H: TNF-{alpha} regulates TGF-{beta}-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-Moesin interaction. J Biol Chem 285: 4060-4073, 2010.
14. Fluge O, Bruland O, Akslen LA, Lillehaug JR and Varhaug JE: Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 16: 161-175, 2006.
15. Choi YL, Kim MK, Suh JW, Han J, Kim JH, Yang JH and Nam SJ: Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. J Korean Med Sci 20: 853-859, 2005.
16. Graff JR, Greenberg VE, Herman JG, Westra WH, Boghaert ER, Ain KB, Saji M, Zeiger MA, Zimmer SG and Baylin SB: Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58: 2063-2066, 1998.
17. Hoque MO, Rosenbaum E, Westra WH, Xing M, Ladenson P, Zeiger MA, Sidransky D and Umbricht CB: Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab 90: 4011-4018, 2005.
18. Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, Saji M and Ringel MD: Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci USA 104: 2803-2808, 2007.
19. Brecelj E, Frkovic Grazio S, Auersperg M and Bracko M: Prognostic value of E-cadherin expression in thyroid follicular carcinoma. Eur J Surg Oncol 31: 544-548, 2005.
20. Rocha AS, Soares P, Fonseca E, Cameselle-Teijeiro J, Oliveira MC and Sobrinho-Simoes M: E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 42: 580-587, 2003.
21. Graff JR, Gabrielson E, Fujii H, Baylin SB and Herman JG: Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275: 2727-2732, 2000.
22. Gupta A, Deshpande CG and Badve S: Role of E-cadherins in development of lymphatic tumor emboli. Cancer 97: 2341-2347, 2003.
23. Batistatou A, Charalabopoulos AK, Scopa CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ and Charalabopoulos K: Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virchows Arch 448: 763-767, 2006.
24. Friedl P, Noble PB, Walton PA, Laird DW, Chauvin PJ, Tabah RJ, Black M and Zanker KS: Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 55: 4557-4560, 1995.
25. Nabeshima K, Moriyama T, Asada Y, Komada N, Inoue T, Kataoka H, Sumiyoshi A and Koono M: Ultrastructural study of TPATPATPA-induced cell motility: human well-differentiated rectal adenocarcinoma cells move as coherent sheets via localized modulation of cell-cell adhesion. Clin Exp Metastasis 13: 499-508, 1995.
26. Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G and Zanker KS: Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 56: 4556-4561, 1996.